Periodontal Therapeutics Market Research Report Information By Type (Chronic Periodontitis, Aggressive Periodontitis and Necrotizing Periodontal), By Treatment (Systematic Antibiotics and Others), By End Users (Dental Hospital and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Periodontal Therapeutic Market, by Types

6.1 Introduction

6.2 Gingivitis

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.3 Chronic periodontitis

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.4 Aggressive periodontitis

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.5 Necrotizing periodontal

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

Chapter 7. Global Periodontal Therapeutic Market, by Treatment

7.1 Introduction

7.2 Systematic Antibiotics

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.2.1 Doxycycline

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.2.2 Minocycline

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.2.3 Metronidazole

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.2.4 Others

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.3 Local Antibiotics

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.3.1 Arestin

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.3.2 Chlorhexidine

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.3.3 Others

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

Chapter 8. Global Periodontal Therapeutic Market, by End-Users

8.1 Introduction

8.2 Dental Clinic

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–202

8.3 Hospitals

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.4 Others

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

Chapter 9. Global Periodontal Therapeutic Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Fibrocell Sciences, Inc

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Tolmar Inc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Eli Lilly & Company

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Align Technology Inc.

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Dentsply International

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 3M-ESPE

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Ultradent Products Inc

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11. 8 Nobel Biocare Holdings AG

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11. 9 Glidewell Laboratories, Inc

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Orapharma

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Kaken Pharmaceutical

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.12 Valeant Pharmaceuticals Int. Inc

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11. 13 Den-Mat Holdings

11. 13.1Overview

11. 13.2Product Overview

11. 13.3Financials

11. 13.4Key Developments

11. 13.5SWOT Analysis

11. 14 Mallinckrodt Pharmaceuticals

11. 14.1Overview

11. 14.2Product Overview

11. 14.3Financials

11. 14.4Key Developments

11. 14.5SWOT Analysis

11. 15 Purdue Pharma L.P

11. 15.1Overview

11. 15.2Product Overview

11. 15.3Financials

11. 15.4Key Developments

11. 15.5SWOT Analysis

11. 16 Teva Pharmaceutical Industries Limited

11.16.1Overview

11.16.2Product Overview

11.16.3Financials

11.16.4Key Developments

11.16.5SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Global Periodontal Therapeutic Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Periodontal Therapeutic Market Synopsis, 2023–2030

Table 2 Global Periodontal Therapeutic Market Estimates and Forecast, 2023–2030 (USD Million)

Table 3 Global Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 4 Global Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 5 Global Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 6 Global Periodontal Therapeutic Market, by Region, 2023–2030(USD Million)

Table 7 North America: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 8 North America: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 9 North America: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 10 North America: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

Table 11 US: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 12 US: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 13 US: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 14 US: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

Table 15 Canada: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 16 Canada: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 17 Canada: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 18 Canada: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

Table 19 South America: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 20 South America: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 21 South America: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 22 South America: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

Table 23 Europe: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 24 Europe: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 25 Europe: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 26 Europe: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

Table 27 Western Europe: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 28 Western Europe: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 29 Western Europe: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 30 Western Europe: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

Table 31 Eastern Europe: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 32 Eastern Europe: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 33 Eastern Europe: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 34 Eastern Europe: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

Table 35 Asia-Pacific: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 36 Asia-Pacific: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 37 Asia-Pacific: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 38 Asia-Pacific: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

Table 39 Middle East & Africa: Periodontal Therapeutic Market, by Types, 2023–2030 (USD Million)

Table 40 Middle East & Africa: Periodontal Therapeutic Market, by Treatment, 2023–2030 (USD Million)

Table 41 Middle East & Africa: Periodontal Therapeutic Market, by End-User, 2023–2030 (USD Million)

Table 42 Middle East & Africa: Periodontal Therapeutic Market, by Region, 2023–2030 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Periodontal Therapeutic Market

Figure 3 Segmentation Market Dynamics for Global Periodontal Therapeutic Market

Figure 4 Global Periodontal Therapeutic Market Share, by Types, 2023(%)

Figure 5 Global Periodontal Therapeutic Market Share, by Treatment, 2023(%)

Figure 6 Global Periodontal Therapeutic Market Share, by End-User, 2023(%)

Figure 7 Global Periodontal Therapeutic Market Share, by Region, 2023(%)

Figure 8 North America: Periodontal Therapeutic Market Share, by Country, 2023(%)

Figure 9 Europe: Periodontal Therapeutic Market Share, by Country, 2023(%)

Figure 10 Asia-Pacific: Periodontal Therapeutic Market Share, by Country, 2023(%)

Figure 11 Middle East & Africa: Periodontal Therapeutic Market Share, by Country, 2023(%)

Figure 12 Global Periodontal Therapeutic Market: Company Share Analysis, 2023(%)

Figure 13 Fibrocell Sciences, Inc: Key Financials

Figure 14 Fibrocell Sciences, Inc: Segmental Revenue

Figure 15 Fibrocell Sciences, Inc: Geographical Revenue

Figure 16 Tolmar Inc: Key Financials

Figure 17 Tolmar Inc: Segmental Revenue

Figure 18 Tolmar Inc: Geographical Revenue

Figure 19 Eli Lilly & Company: Key Financials

Figure 20 Eli Lilly & Company: Segmental Revenue

Figure 21 Eli Lilly & Company: Geographical Revenue

Figure 22 Align Technology Inc: Key Financials

Figure 23 Align Technology Inc: Segmental Revenue

Figure 24 Align Technology Inc: Geographical Revenue

Figure 25 DENTSPLY INTERNATIONAL.: Key Financials

Figure 26 DENTSPLY INTERNATIONAL.: Segmental Revenue

Figure 27 DENTSPLY INTERNATIONAL.: Geographical Revenue

Figure 28 3M-ESPE.: Key Financials

Figure 29 3M-ESPE.: Segmental Revenue

Figure 30 3M-ESPE.: Geographical Revenue

Figure 31 Ultradent Products Inc: Key Financials

Figure 32 Ultradent Products Inc: Segmental Revenue

Figure 33 Ultradent Products Inc: Geographical Revenue

Figure 34 Nobel Biocare Holdings AG: Key Financials

Figure 35 Nobel Biocare Holdings AG: Segmental Revenue

Figure 36 Nobel Biocare Holdings AG: Geographical Revenue

Figure 37 Glidewell Laboratories, Inc: Key Financials

Figure 38 Glidewell Laboratories, Inc: Segmental Revenue

Figure 39 Glidewell Laboratories, Inc: Geographical Revenue

Figure 40 Orapharma: Key Financials

Figure 41 Orapharma: Segmental Revenue

Figure 42 Orapharma: Geographical Revenue

Figure 43 Kaken Pharmaceutical: Key Financials

Figure 44 Kaken Pharmaceutical: Segmental Revenue

Figure 45 Kaken Pharmaceutical: Geographical Revenue

Figure 46 Valeant Pharmaceuticals Int. Inc: Key Financials

Figure 47 Valeant Pharmaceuticals Int. Inc: Segmental Revenue

Figure 48 Valeant Pharmaceuticals Int. Inc: Geographical Revenue

Figure 49 Den-Mat Holdings.: Key Financials

Figure 50 Den-Mat Holdings.: Segmental Revenue

Figure 51 Den-Mat Holdings.: Geographical Revenue

Figure 52 Mallinckrodt Pharmaceuticals: Key Financials

Figure 53 Mallinckrodt Pharmaceuticals: Segmental Revenue

Figure 54 Mallinckrodt Pharmaceuticals: Geographical Revenue

Figure 55 Purdue Pharma L.P: Key Financials

Figure 56 Purdue Pharma L.P: Segmental Revenue

Figure 57 Purdue Pharma L.P: Geographical Revenue

Figure 58 Teva Pharmaceutical Industries Limited: Key Financials

Figure 59 Teva Pharmaceutical Industries Limited: Segmental Revenue

Figure 60 Teva Pharmaceutical Industries Limited: Geographical Revenue